MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways

Volume: 38, Issue: 32, Pages: 6035 - 6050
Published: Jul 5, 2019
Abstract
Ovarian cancer is the most lethal gynecological malignancy due to the silent nature on its early onset and the rapid acquisition of drug resistance. Histologically heterogeneous, it includes several subtypes with different mutational landscapes, hampering the development of effective targeted therapies. Non-coding RNAs are emerging as potential new therapeutic targets in cancer. To search for a microRNA signature related to ovarian carcinomas...
Paper Details
Title
MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways
Published Date
Jul 5, 2019
Journal
Volume
38
Issue
32
Pages
6035 - 6050
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.